Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The MDS Channel

Explore the latest updates, including expert interviews, features, podcasts and e-learning

The MDS Channel on VJHemOnc is supported by Bristol Myers Squibb,Geron and Syros Pharmaceuticals. This supporter has no influence over the production of the content.

Welcome to The Myelodysplastic Syndromes (MDS) Channel

Explore all things new and exciting in MDS, with exclusive insights, must-know news, and unique expert perspectives, courtesy of The MDS Channel.

Much research is underway to address the paucity of available options in MDS and many new agents, targets, and treatment approaches are in development or under investigation, such as novel HMA-based combinations, immunotherapies, and other newer agents. With the support of a world-leading Editorial Board, VJHemOnc brings you informative interviews, roundtable discussions, feature articles, and podcasts; a one-stop source for the key MDS news!


ESH MDS 2024
ASH 2023
SOHO 2023
EHA 2023
MDS 2023
BSH 2023


Trial Updates
Disease Biology